Articles On Micro-X (ASX:MX1)

Title Source Codes Date
ASX health Stocks: Imugene up on PD1-Vaxx cancer study expansion plans

Leader of the ASX health stocks today is Imugene (ASX:IMU) up 4.11% after announcing plans to present its PD1-Vaxx cancer checkpoint immunotherapy program at the ESMO Congress 2021 Annual Meeting in Paris. The company says clinical results...

Stockhead MX1 2 years ago
Closing Bell: Energy leads the ASX to another gain, but one stock gained 265pc

It was another day of gains for the ASX led by the energy sector. The ASX 200 rose by 0.116% to close at 7,437 while the ASX Emerging Companies Index rose 0.56% to close at 2,527. Although there was an even number of winners and losers amon...

Stockhead MX1 2 years ago
Hidden Gems Webinar Recap – Perpetual, OLL, FCT, LBT & MX1

ShareCafeHidden Gems Webinar Recap – Perpetual, OLL, FCT, LBT & MX1 Catch up on the full webinar with a keynote presentation from Perpetual & presentations from OpenLearning (ASX: OLL), First Wave Cloud Technology (ASX: FCT), LBT I...

ShareCafe MX1 2 years ago
Miniaturising X-Ray

ShareCafeMiniaturising X-Ray Peter Rowland – Managing Director – Micro-X Ltd is an award-winning ASX listed x-ray technology company. Miniaturising X-RayCompany News

ShareCafe MX1 2 years ago
Check Up: Dimerix and ImpediMed announced breakthroughs, while earnings dominate news flow in August

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

Stockhead MX1 2 years ago
FNArena Corporate Results Monitor – 30-08-2021

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AFG)) - Australian Finance Group ((BGA)) - Bega Cheese ((BEX)) - BikeExchange ((DTC)) - Damstra holdings ((DDH)) - DDH1 ((GDG)) - Generation Development ((GNX)) - Genex...

FNArena MX1 2 years ago
12 Emerging ASX listed Tech Shares with a growth trajectory

Highlights Low interest rate scenario is conducive for growth stocks. The technology sector has witnessed a major tail wind since the rapid digitisation post the COVID-19 outbreak. Knosys is to acquire a leading Library Management Sof...

Kalkine Media MX1 2 years ago
Check up: Rhinomed (ASX:RNO) soars with NSW COVID contract, and genetic testing fails to impress

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

Stockhead MX1 2 years ago
Trading Places: Who’s betting on return to office stocks?

Trading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers and other famous investors over the last fortnight. Specifically, Stockhead tracks substantial shareholder movements, being shareholders hold...

Stockhead MX1 2 years ago
Check Up: Hexima roars 70pc on clinical trials, while Bionomics heads for a US dual listing

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

Stockhead MX1 2 years ago
Check Up: Rhythm (ASX:RHY) plans US expansion, the US$1.5b dog dermatitis market and data dumps drive stocks down

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

Stockhead MX1 2 years ago
Check up: A mixed bag for ASX health stocks as FDA decides fates at the flip of a coin

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Stockhead MX1 2 years ago
Dr Boreham’s Crucible: Don’t cry for me, Argenica

We’ve all heard the maxim that ‘time is money’, but in the case of stroke victims ‘time is brain’. From the moment of the dreaded incident, the clock is ticking on getting the patient to a suitably equipped hospital ASAP because millions of...

Stockhead MX1 2 years ago
Last Orders: ASX begins FY22 down 0.65 per cent

It wasn’t a happy start to the new financial year for Australia’s bourse, which lost nearly two thirds of one per cent today. Likewise, the ASX200, which rose 22% in FY21, closed down 0.65% to 7,266. Meanwhile, the ASX Emerging Companies In...

Stockhead MX1 2 years ago
ScoPo’s Powerplays: Buying opportunities in a volatile week and stock downgrades

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

Stockhead MX1 2 years ago
Check Up: As Alzheimer’s grabs the spotlight, these ASX biotech stocks also impressed

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

Stockhead MX1 2 years ago
ScoPo’s Powerplays: Mental health takes centre stage; Actinogen to progress Alzheimer’s study

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week It has been...

Stockhead MX1 2 years ago
Under the Microscope: Peter Rowland, Managing Director of Micro-X (ASX:MX1)

Peter Rowland, Managing Director of Micro-X (MX1) explains the significance of the next generation X-ray technology for global health and security markets.

Morgans MX1 2 years ago
Why Advanced Human and other ASX imaging stocks have more than doubled in 12 months

The diagnostics imaging industry has come a long way since the days of X-rays and CT scans – two technologies that have been around for decades. Although they have not been replaced entirely, a breed of new ASX small caps have emerged over...

Stockhead MX1 2 years ago
Revolutionary X-ray Technology From Australia to Transform American Airport Security

SeaTac chosen for Micro-X Inc’s USA headquartersOfficial Opening at 10 am PDT, Friday May 28855 S 192nd Street, Suite B600, Seattle, WA 98148 With: Congressman Adam Smith, chair of the House Armed Services Committee Brigadier Hugh Meggit...

FNArena MX1 2 years ago
ScoPo’s Powerplays: The immune oncology space finally gets long overdue attention

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Healthcare...

Stockhead MX1 2 years ago
Last Orders: Hump Day ends large caps down and small caps up

Large and small caps had diverging fates on the ASX today with the former closing 0.32 per cent down from yesterday at 7,093 points while the ASX Emerging Companies Index rose 1.21 per cent to close at 2,159. The various ASX sectors were al...

Stockhead MX1 2 years ago
Market highlights and 5 ASX small caps to watch on Wednesday

Wall Street edges lower All major US indices fell overnight, as new US home sales slid by more than forecast. Dow Jones index was down by 0.24%, S&P500 by 0.21%, and tech heavy NASDAQ by 0.03%. The equity market dropped as the weak home...

Stockhead MX1 2 years ago
Morgans picks small cap ASX shares with near-term share price catalysts

The market looks caught in a fairly tight trading band since April as bulls and bears look to see who blinks first. In this climate, a good way to pick ASX shares to buy is to target those with positive near-term catalysts, according to Mo...

Motley Fool MX1 2 years ago
Trading Places: As other ASX fundies exited CleanSpace, here’s one that sees a buy

If you want to know which ASX stocks fund managers and famous investors are putting their money into we’ve been keeping track of substantial holder buys (and sells). Trading Places is Stockhead’s recap of the substantial holder movements am...

Stockhead MX1 2 years ago
ScoPo’s Powerplays: Budget boost and inflation fears meet head on

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Healthcare...

Stockhead MX1 2 years ago
Diagnostic imaging: which stock will become the next Pro Medicus?

For all the leaps and bounds in medical science, the know-how behind detecting diseases hasn’t changed much in decades – or even centuries. Take X-rays, which are widely used despite the wee problem of irradiating the patients. And that’s b...

SmallCaps MX1 2 years ago
ScoPo’s Powerplays: Health sector trades sideways but M&A plays coloured the week

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Themes of the week Healthcare f...

Stockhead MX1 2 years ago
Capital Raisings Recap: Nearly $10 billion has already been raised in 2021

The capital raisings boom on the ASX is continuing in 2021 with nearly $10 billion raised in the first four months of the year. Across 325 deals, ASX companies have raised $9.878 billion in capital amidst IPOs, placements and rights issues....

Stockhead MX1 2 years ago
Hidden Gems Webinar Recap – PFG, EXL, MX1, BRU

ShareCafeHidden Gems Webinar Recap – PFG, EXL, MX1, BRU Catch up on the full webinar with a keynote presentation from Prime Financial Group (ASX: PFG), Elixinol Global (ASX: EXL), Micro-X (ASX: MX1) & Buru Energy (ASX: BRU) Hidden Gems...

ShareCafe MX1 3 years ago
Micro-X (ASX: MX1) – Hidden Gems Webinar Presentation

ShareCafeMicro-X (ASX: MX1) – Hidden Gems Webinar Presentation Presenter – Peter Rowland – Managing Director – Micro–X Ltd is an award winning x-ray technology company. Micro–X Ltd is  a pioneer of a global revolution in medical and securi...

ShareCafe MX1 3 years ago
ScoPo’s powerplays: Antisense ‘looks like it wants to run harder’

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The ASX he...

Stockhead MX1 3 years ago
Scopo’s powerplays: Healthcare steadies, and Mach7 ‘looks really interesting’

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week After a re...

Stockhead MX1 3 years ago
Check Up: Oneview leads healthcare sector after ‘investor awareness’ pact

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Stockhead MX1 3 years ago
Last Orders: ASX up 0.87pc; all sectors shining except energy and materials

The ASX had a positive day today gaining 0.8 per cent and all sectors finished in the green except resources and energy. Resources and Energy stocks fell 0.24 per cent and 0.55 per cent but the broader ASX 200 rose 0.87 per cent and all oth...

Stockhead MX1 3 years ago
Micro-X (ASX:MX1) shares riding high on MRFF Funding Award

Source: OSABEE ,Shutterstock Summary Micro-X received MRFF funding for lightweight brain CT scanner testing via MRFF funding. The Company is confident that the brain CT product would be the fourth pillar of its commercialisation strat...

Kalkine Media MX1 3 years ago
Micro-X gains after portable X-ray company wins $8m stroke grant

Micro-X (ASX:MX1) shares have hit a more than three-year high after the Brisbane-based portable imaging company announced it was in ... Read More The post Micro-X gains after portable X-ray company wins $8m stroke grant appeared first on St...

Stockhead MX1 3 years ago
X-ray tech venture Micro-X raises $30 million for US expansion

Micro-X has received funding commitments of $30.5 million to help expand its US footprint and fast-track new lightweight x-ray products. The publicly-listed company announced to the Australian Securities Exchange (ASX: MX1) this morning it...

Startup Daily MX1 3 years ago
X-ray maker Micro-X seeks $32.5 million; taps two brokers

ASX-listed x-ray products maker Micro-X has landed in front of small cap fund managers, seeking a cash injection to build out its United States operations.

AFR MX1 3 years ago
ScoPo’s powerplays: Bullish on mobile X-ray company Micro-X

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains ... Read More The post ScoPo’s powerplays: Bullish on mobile X-ray company Micro-X appeared first on Stockhead.

Stockhead MX1 3 years ago
ScoPo’s powerplays: Bullish on mobile X-ray company Micro-X

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains ... Read More The post ScoPo’s powerplays: Bullish on mobile X-ray company Micro-X appeared first on Stockhead.

Stockhead MX1 3 years ago
Dr Boreham’s Crucible: Do these mobile X-ray deals prime Micro-X to explode?

For smug non-Croweaters who claim the closest Adelaide has got to technical innovation is a pie floater: shame on you. ... Read More The post Dr Boreham’s Crucible: Do these mobile X-ray deals prime Micro-X to explode? appeared first on Sto...

Stockhead MX1 3 years ago
Micro-X (ASX:MX1) secures $1.95 million R&D tax incentive

08 Jan 2021 - X-ray tech company, Micro-X (ASX:MX1) has secured a research and development tax incentive for the financial year ended 30 June 2020.

FNN MX1 3 years ago
US Homeland Security selects Micro-X to develop self-screening x-ray technology for airports

The US Government’s Department of Homeland Security has selected Micro-X (ASX: MX1) to develop the its new concept for airport passenger self-screening. Micro-X was chosen after a competitive process that involved submitting a white paper....

SmallCaps MX1 3 years ago
The Quickstep (ASX:QHL) share price is shooting higher today. Here’s why

The Quickstep Holdings Limited (ASX: QHL) share price is shooting higher today following the release of its first quarter results. In late-morning trade, shares in the aerospace manufacturer are up 4% to 7.8 cents after earlier reaching as...

Motley Fool MX1 3 years ago
Scopo’s Health Powerplays: Show me the (grant) money

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Themes of the week We’re coming...

Stockhead MX1 3 years ago
FNArena Corporate Results Monitor – 31-08-2020

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ALG)) - Ardent Leisure ((AMS)) - Atomos ((AFG)) - Australian Finance ((ASG)) - Autosports Group ((BLD)) - Boral ((CWP)) - Cedar Woods Properties ((CGC)) - Costa Group ((...

FNArena MX1 3 years ago
Scopo’s health powerplays: A healthy earnings season

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Earnings s...

Stockhead MX1 3 years ago
For medtech company Micro-X, COVID-19 highlighted the importance of being prepared

The COVID-19 pandemic left a lot of medical device companies scrambling to keep up with the unprecedented disruption. And when we caught up with Micro-X (ASX:MX1) CEO Peter Rowland earlier this week, he said the main challenge was presented...

Stockhead MX1 3 years ago
Scopo’s powerplays: It just won’t go down!

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Scott Powe...

Stockhead MX1 3 years ago